A retrospective cohort study was conducted to assess the effect of surgical left atrial appendage occlusion on risk for readmission due to thromboembolism in older patients.
Investigators assessed the presence of cerebral microbleeds as a biomarker for identifying patients at increased risk for intracranial hemorrhage as a result of anticoagulation for atrial fibrillation.
Investigators retrospectively reviewed treatment patterns and long-term outcomes in 30,626 patients with ischemic stroke and AF who had these data recorded in 4 Danish healthcare registries.
Investigators conducted 2 retrospective cohort studies to determine whether patients with resolved AF were at an increased risk for stroke or TIA and all-cause mortality compared with matched controls with unresolved AF.
For patients with CKD and atrial fibrillation, anticoagulants are linked with an increased risk of ischemic stroke.
Blacks are at an increased risk of developing ischemic stroke, before or after atrial fibrillation diagnosis.
CHA2DS2-VASc score assessment is more predictive of ischemic stroke in patients with atrial fibrillation than the baseline score.
Although there was little difference in efficacy, apixaban did have a better safety profile than warfarin, dabigatran, and rivaroxaban.
Updated antithrombotic therapy recommendations for patients with atrial fibrillation have been provided.
Ablation is associated with reduced risk of recurrent stroke for patients with artrial fibrillation.
Risk scores help identify high-risk patients who may benefit from intervention.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
The investigators noted that rivaroxaban was associated with significantly reduced length of hospital stay compared with warfarin.
Dual therapy was associated with a significantly higher bleeding risk.
Delays in anticoagulation treatment resulted in increased risk for dementia.
Neglecting abnormalities in ECG readings could result in serious acute cardiac events in patients presenting with stroke.
Patients taking apixaban showed significantly less intracranial hemorrhage (0.33% per year) vs patients taking warfarin (0.80% per year), no matter the type and location.
More than 80% of ischemic stroke patients weren't getting adequate anticoagulation therapy.
Clinicians should closely monitor patients with atrial fibrillation, especially if they are female and of increasing age.
Early intervention in patients with heart failure or atrial fibrillation may help delay or prevent the onset of mild dementia.
It is not clear if identifying atrial fibrillation in an effort to prevent stroke would be an effective preventive strategy.
The increased risk of stroke was only observed among patients with diabetes controlled by insulin.
At 1 year, no difference in complications was observed between the 2 age groups.
Twelve months after AFib ablation, risk of recurrent stroke or AFib is low.
Only 46% of patients with indications received OACs at discharge from the hospital.
32.1% believed that heart attack is a major risk factor of AF, which is incorrect.
Reduced REM sleep was correlated with a 23% increased risk of atrial fibrillation, while insomnia was associated with a 29% increased risk.
Long episodes of AT/AF were more likely to be associated with clinical events than short episodes.
Patients with untreated OSA face an increased risk of complications.
Treating older patients with a vitamin K antagonist may be warranted since thrombosis risk is more markedly increased than bleeding risk with rising age.
Neurology Advisor Articles
- OCD in Duchenne Muscular Dystrophy Features Distinct Phenotype, Associated Symptoms
- History of Migraine Associated With Higher Risk for Cochlear Disorders
- Patent Foramen Ovale Closure for Stroke Prevention: Key Principles for Clinical Practice
- Vagus Nerve Stimulation in Pediatric Epilepsy: Weighing the Risks and Benefits
- A Model for Predicting Quality of Life Improvements After Deep Brain Stimulation
- Some Statins May Be Associated With Cognition, Memory Deficits
- Neuropathic Pain Treatments
- Cannabis for Multiple Sclerosis: Prescriber's Perspective
- New Monoclonal Antibody BAN2401 Reduces Amyloid Plaques, Improves Cognition in Alzheimer's
- Nonpharmacologic Interventions for Alzheimer's Have Greater Impact on Outcomes Than Currently Available Medications
- Apomorphine Infusions Improves Off Time Associated With Parkinson Disease
- FDA Grants Orphan Drug Status to Angelman Syndrome Treatment
- Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines
- Clinical, Radiologic Markers Predictive of Cortical Superficial Siderosis in ICH Identified
- Migraine Pain Location May Not Have Clinical Implications